← Eichor
Condition: Pet Mri Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pet Mri

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768
High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469
Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07400224
The EMINENCE Study - PET/MR Imaging of Head Neck Cancer
Phase N/A · 2 location(s) · Norwegian University of Science and Technology · NCT04612075
The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Phase N/A · 1 location(s) · University of Bonn · NCT06460142
Precision Medicine in the Depression Treatment
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT05616559
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06305390
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 · 1 location(s) · University of Florida · NCT07220720
Exercise & Brain Energetics in PD
NA · 1 location(s) · Pacific Parkinson's Research Centre · NCT04426786
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
Phase N/A · 1 location(s) · Region Västerbotten · NCT05855941
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
Phase N/A · 2 location(s) · Leiden University Medical Center · NCT04832620
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR
Phase N/A · 1 location(s) · University of Exeter · NCT05205291
Imaging of Endometriosis With Total-body PET-CT (PET-Endo)
Phase N/A · 1 location(s) · University of Edinburgh · NCT07523997
CANF-Comb-II PET-MR in Atherosclerosis Multisite
Phase N/A · 2 location(s) · Washington University School of Medicine · NCT05838547
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospec
NA · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06334965
Imaging Immune Activation in HIV by PET-MR
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT03684655
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Phase 1/Phase 2 · 1 location(s) · David Wilson · NCT05374278
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arr
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06591260
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer
NA · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT06421142
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
Phase 4 · 1 location(s) · Hsiao-Ying Wey · NCT06763172
Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study
Phase N/A · 1 location(s) · The First Affiliated Hospital of Dalian Medical University · NCT06250842
PET/MRI/EEG Imaging Study in Epilepsy
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06974305
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
Phase 2 · 1 location(s) · University of North Carolina, Chapel Hill · NCT05480995
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT05088798
Assessment of Brain Cognitive Impairment in Breast Cancer
Phase N/A · 1 location(s) · Tang-Du Hospital · NCT05305092
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.